Discussion points
1. Patient/consumer protection in e-commerce:
• effective protection when purchasing on the Internet;
• same degree of protection as in the real marketplace?
• what further actions on the demand side (beyond the booklet Medical products and the Internet)?
• role of national governments;
• partnerships (professional associations, Internet service providers);
• Children/minors and e-commerce:
• vulnerability to advertisements and commercial messages;
• capability to distinguish between advertising and information;
• limitations on advertising to children?
2. The role and limitations of national regulatory authorities:
• reaching health professionals and consumers;
• improving visibility and improving provision of information.
3. Minimum information about suppliers and products offered:
• essential details about the supplier: name of company, physical address, phone, fax, e-mail, name and address of the licensing body through which the company is registered or authorized;
• geographic scope of trade;
• safe and proper handling/storage requirements;
• information (or non-availability of information) on regulatory status of products or on safety or warnings in countries of origin and destination;
• reference/links to sources of independent information on product safety, use, and efficacy;
• actual costs of delivery, postage and handling, insurance, and customs taxes and duties;
• information on applicable law and the jurisdiction for settling disputes;
• requirements for disclosure of (liable) representative in importing country?
4. Intellectual property and e-commerce:
• international differences in trade names and patent validity;
• challenges to national policies on parallel imports;
• laws and legal rules not harmonized at the international level.
5. Responsibility of exporters and importers/consumers:
• is compliance with importing country’s regulations the responsibility of the exporter or the importer?
• forbid ‘distance shopping’ (e.g., Germany)?
• establish direct-to-consumer e-export licences?
6. Codes of conduct and beyond:
• ‘ethical/fair’ trade guidelines/principles;
• is there a role for manufacturers?
• what challenges for pharmacists’ associations?
• is there a role/challenge for Internet service providers?
• towards an ad hoc global regulation of international e-trade?
• limits to the rights of governments to regulate business to protect consumers and public health?
7. Observatories:
• who should/can monitor e-offers?
• label for legitimate suppliers?
• is there a role/challenge for Internet service providers?
• how can we ensure that international harmonization does not reduce the level of protection provided by existing national standards?